Not logged in.png)
Share.png)
SaveShare Save Share Save Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cells (vol 112, pg 1895, 2015)
Caiazza, F.; Mcgowan, P. M.; Mullooly, M.; Murray, A.; Synnott, N.; O'Donovan, N.; Flanagan, L.; Tape, C. J.; Murphy, G.; Crown, J.; Duffy, M. J. Share Save Rare germline deleterious variants increase susceptibility for lung cancerSang, Jian; Zhang, Tongwu; Kim, Jung; Li, Mengying; Pesatori, Angela C.; Consonni, Dario; Song, Lei; Liu, Jia; Zhao, Wei; Hoang, Phuc H.; Campbell, Dave S.; Feng, James; D'Arcy, Monica E.; Synnott, Naoise; Chen, Yingxi; Wu, Zeni; Zhu, Bin; Yang, Xiaohong R.; Brown, Kevin M.; Choi, Jiyeon; Shi, Jianxin; Landi, Maria Teresa Share Save Share Save Comparing the association of self-reported race-ethnicity and genetic ancestry with all-cause mortality: A pan-cancer survivor analysis in the PLCO Screening TrialBrown, Derek W.; Vo, Jacqueline B.; Buller, Ian D.; Synnott, Naoise C.; Jones, Rena R.; Landi, Maria Teresa; Huang, Wen-Yi; Machiela, Mitchell J.; de Gonzalez, Amy Berrington; Freedman, Neal D. Share Save Characterizing the tumor microenvironment in rare renal cancer histological typesSynnott, Naoise C.; Poeta, Maria Luana; Costantini, Manuela; Pfeiffer, Ruth M.; Li, Mengying; Golubeva, Yelena; Lawrence, Scott; Mutreja, Karun; Amoreo, Carla; Dabrowska, Malgorzata; Simone, Giuseppe; Pescarmona, Edoardo; Lenz, Petra; Olanich, Mary; Duggan, Maire; Abubakar, Mustapha; Fazio, Vito Michele; Gallucci, Michele; Sentinelli, Steno; Landi, Maria Teresa Share Save Tracing Lung Cancer Risk Factors Through Mutational Signatures in Never-SmokersLandi, Maria Teresa; Synnott, Naoise C.; Rosenbaum, Jennifer; Zhang, Tongwu; Zhu, Bin; Shi, Jianxin; Zhao, Wei; Kebede, Michael; Sang, Jian; Choi, Jiyeon; Mendoza, Laura; Pacheco, Marwil; Hicks, Belynda; Caporaso, Neil E.; Abubakar, Mustapha; Gordenin, Dmitry A.; Wedge, David C.; Alexandrov, Ludmil B.; Rothman, Nathaniel; Lan, Qing; Garcia-Closas, Montserrat; Chanock, Stephen J. Share Save Share Save Share Save Mutant p53 as a therapeutic target for the treatment of triple-negative breast cancer: Preclinical investigation with the anti-p53 drug, PK11007Synnott, Naoise C.; Bauer, Matthias R.; Madden, Stephen; Murray, Alyson; Klinger, Rut; O'Donovan, Norma; O'Connor, Darran; Gallagher, William M.; Crown, John; Fersht, Alan R.; Duffy, Michael J. Share Save Share Save Share Save Share Save Mutant p53: a novel target for the treatment of patients with triple-negative breast cancer?Synnott, N. C.; Murray, A.; McGowan, P. M.; Kiely, M.; Kiely, P. A.; O'Donovan, N.; O'Connor, D. P.; Gallagher, W. M.; Crown, J.; Duffy, M. J. Share Save Share Save Targeting ADAM-17 with an inhibitory monoclonal antibody has antitumour effects in triple-negative breast cancer cellsCaiazza, F.; McGowan, P. M.; Mullooly, M.; Murray, A.; Synnott, N.; O'Donovan, N.; Flanagan, L.; Tape, C. J.; Murphy, G.; Crown, J.; Duffy, M. J. Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
